TrialMolecular therapy : the journal of the American Society of Gene Therapy2009

Phase I/II and phase II studies of targeted gene delivery in vivo: intravenous Rexin-G for chemotherapy-resistant sarcoma and osteosarcoma.

Sant P Chawla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.